or Try an Advanced Search...

    Drug Delivery Technology Stocks List

    Symbol Grade Name % Change
    EPRX B Eupraxia Pharmaceuticals Inc. 0.00
    PCRX C Pacira Pharmaceuticals, Inc. 1.41
    DRRX F DURECT Corporation -9.82
    TTNP F Titan Pharmaceuticals, Inc. -4.64
    BDRX F Biodexa Pharmaceuticals plc -25.51
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Drug Delivery Pharmaceutical Schizophrenia Bupivacaine Cancer Chemical Compounds Chronic Condition Chronic Pain Medicine Morphinans Opioids Organic Compounds Pain Acute Pain Adhd Antipsychotic Arthritis Attention Deficit Hyperactivity Disorder Atypical Antipsychotics Brain Tumor

    Related ETFs - A few ETFs which own one or more of the above listed Drug Delivery Technology stocks.

    Symbol Grade Name Weight
    PJP C PowerShares Dynamic Pharmaceuticals 3.98
    XPH C SPDR S&P Pharmaceuticals ETF 2.01
    PILL C Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF 1.27
    SFLO B VictoryShares Small Cap Free Cash Flow ETF 1.21
    CALF B Pacer US Small Cap Cash Cows 100 ETF 0.88
    View all Drug Delivery Technology ETFs...
    Compare ETFs
    Compare PILL to SFLO Compare PJP to SFLO Compare XPH to SFLO

        Drug Delivery Technology Stocks Recent News

        Date Stock Title
        Nov 14 PCRX Pacira Announces 104-Week Safety and Efficacy Data Following Local Administration of PCRX-201 for Moderate to Severe Osteoarthritis of the Knee
        Nov 14 DRRX Q3 2024 DURECT Corp Earnings Call
        Nov 14 DRRX Durect Corp (DRRX) Q3 2024 Earnings Call Highlights: Revenue Growth Amid Cost Reductions and ...
        Nov 14 DRRX DURECT Corporation (DRRX) Q3 2024 Earnings Call Transcript
        Nov 13 DRRX Durect (DRRX) Reports Q3 Loss, Misses Revenue Estimates
        Nov 13 EPRX Eupraxia Pharmaceuticals' CEO Dr. James Helliwell to Participate in Webinar Event, "Eosinophilic Esophagitis: The Emerging Digestive Disorder Frequently Misdiagnosed", on November 15, 2024
        Nov 13 DRRX Durect: Q3 Earnings Snapshot
        Nov 13 DRRX DURECT GAAP EPS of -$0.14 beats by $0.03, revenue of $1.92M misses by $0.06M
        Nov 13 DRRX DURECT Corporation Reports Third Quarter 2024 Financial Results and Provides Business Update
        Nov 13 DRRX Earnings Scheduled For November 13, 2024
        Nov 12 EPRX Eupraxia Pharmaceuticals Announces Positive Data from Fifth Cohort of RESOLVE Phase 1b/2a Trial of EP-104GI for Treatment of Eosinophilic Esophagitis
        Nov 12 DRRX DURECT Q3 2024 Earnings Preview
        Nov 12 BDRX Biodexa Pharmaceuticals PLC (“Biodexa” or the “Company”) Regains Compliance For Continued Listing on Nasdaq
        Nov 12 PCRX Pacira BioSciences to Participate in Fireside Chat at Two Upcoming Healthcare Conferences
        Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Drug Delivery Pharmaceutical Schizophrenia Bupivacaine Cancer Chemical Compounds Chronic Condition Chronic Pain Medicine Morphinans Opioids Organic Compounds Pain Acute Pain Adhd Antipsychotic Arthritis Attention Deficit Hyperactivity Disorder Atypical Antipsychotics Brain Tumor
        Drug Delivery Technology

        Drug Delivery Technology is a field of research and development that focuses on the design and development of systems and devices for the delivery of therapeutic agents to the body. This technology includes the development of drug delivery systems such as transdermal patches, inhalers, implants, and nanoparticles, as well as the development of drug delivery devices such as syringes, pumps, and catheters. The goal of drug delivery technology is to improve the efficacy and safety of drug delivery, while also reducing the cost of drug delivery.

        Browse All Tags